Dana-Farber/Brigham and Women’s Cancer Center researchers were granted a $10 million award from the Department of Defense to conduct research to determine if a daily aspirin regimen is beneficial to cancer patients.
In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.
Tags: BreastCancer, Grants, Honors
Rachel Freedman commented on targeted treatments – those that attack a specific
characteristic of a cancer strain – becoming the norm in breast cancer care.
Dr. Mehra Golshan and Dr. Yasuaki Sagara led a study that showed surgery for a very early type of breast cancer does not significantly improve outcomes for patients.
Tags: BreastCancer, Radiation
Rachel Freedman led a study, published in CANCER, that found many women
with breast cancer may lack knowledge regarding their illness.
Dr. Harold Burstein provided insight to dispel the myth that
antiperspirants cause breast cancer.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: